Suppr超能文献

使用 N-丁基-2-氰基丙烯酸酯微创治疗尿瘘:一种有效的一线选择。

Minimally invasive treatment of urinary fistulas using N-butyl-2-cyanoacrylate: a valid first line option.

机构信息

Department of Urology, University of Pisa, Pisa, Italy.

出版信息

BMC Urol. 2013 Oct 24;13:55. doi: 10.1186/1471-2490-13-55.

Abstract

BACKGROUND

A few single case reports and only one clinical series have been published so far about the use of N-butyl-2-cyanoacrylate in the treatment of urinary fistulas persisting after conventional urinary drainage.

CASE PRESENTATION

We treated five patients with a mean age of 59.2 years presenting iatrogenic urinary fistulas which persisted following conventional drainage manouvres. There were 3 calyceal fistulas following open, laparoscopic and robotic removal of renal lesions respectively, one pelvic fistula after orthotopic ileal neobladder and a bilateral dehiscence of uretero-sigmoidostomy. We used open-end catheters of different sizes adopting a retrograde endoscopic approach for cyanoacrylate injection in the renal calyces, while a descending percutaneous approach via the pelvic drain tract and bilateral nephrostomies respectively was used for the pelvic fistulas. Fluoroscopic control was always used during the occlusion procedures. The amount of adhesive injected ranged between 2 and 5 cc and in one case the procedure was repeated. With a median follow-up of 11 months we observed clinical and radiological resolution in 4 cases (80%), while a recurrent and infected calyceal fistula after laparoscopic thermal renal damage during tumor enucleoresection required nephrectomy. No significant complications were documented.

CONCLUSIONS

In an attempt to spare further challenging surgery in patients that had been already operated on recently, minimally invasive occlusion of persistent urinary fistulas with N-butyl-2-cyanoacrylate represents a valid first line treatment, justified in cases when the urinary output is not excessive and there is a favorable ratio between the length and diameter of the fistulous tract.

摘要

背景

目前为止,仅有少数个案报告和一个临床系列报道了使用 N-丁基-2-氰基丙烯酸酯治疗常规引流后持续存在的尿瘘。

病例介绍

我们治疗了 5 名平均年龄为 59.2 岁的患者,他们均因常规引流后出现医源性尿瘘。其中 3 例为肾病变开放、腹腔镜和机器人切除术后的肾盏瘘,1 例为原位回肠新膀胱术后的骨盆瘘,1 例为双侧输尿管-乙状结肠吻合术后的输尿管-乙状结肠吻合口裂开。我们采用不同大小的开放式导管,逆行内镜注射氰基丙烯酸酯进入肾盏,而对于骨盆瘘,则分别采用经盆腔引流管和双侧肾造口的逆行经皮途径。在闭塞过程中始终进行透视控制。注射的粘合剂量在 2 至 5 毫升之间,在 1 例中重复了该过程。在中位随访 11 个月时,我们观察到 4 例(80%)临床和影像学上的缓解,而在腹腔镜热肾损伤肿瘤剜除术中出现的复发性和感染性肾盏瘘需要肾切除术。未记录到明显的并发症。

结论

在尝试为最近接受过手术的患者避免进一步具有挑战性的手术时,使用 N-丁基-2-氰基丙烯酸酯微创闭塞持续性尿瘘是一种有效的一线治疗方法,在尿输出量不高且瘘管长度与直径之比有利的情况下更为合理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e261/4015743/0de58f711c9f/1471-2490-13-55-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验